Meyer Urs A
Founding Editor-in-Chief of Journal of Personalized Medicine, Pharmacology/Neurobiology, Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.
J Pers Med. 2011 Mar 28;1(1):1-4. doi: 10.3390/jpm1010001.
A new vision of personalized medicine or personalized healthcare has evolved as a consequence of remarkable recent advances in technologies that allow to look at individual variation across the entire human genome and to identify personal risk factors behind many diseases and responses to therapy. These advances have greatly increased our understanding of how interactions between the entire genome and nongenomic factors result in health and disease and in therapeutic response. The challenge is now to translate this knowledge into benefits for the individual patient. I expect the Journal of Personalized Medicine to become the premier venue for the rapid and freely accessible publication of high quality manuscripts dealing with this vision for scientists around the world. [...].
由于近期技术取得了显著进展,能够对整个人类基因组中的个体差异进行研究,并识别许多疾病背后的个人风险因素以及对治疗的反应,个性化医疗或个性化保健的新愿景由此应运而生。这些进展极大地增进了我们对整个基因组与非基因组因素之间的相互作用如何导致健康与疾病以及治疗反应的理解。现在面临的挑战是将这些知识转化为个体患者的益处。我期望《个性化医疗杂志》成为一个首要平台,能够快速且免费地发表高质量稿件,供世界各地的科学家探讨这一愿景。[...]